ishita drugs industries ltd Share Price
ISHITADR
₹0.00-₹0.00 (0%) Past Year
₹0.00₹0.00
LH
What’s in news?
Company overview
About
Market cap
| Open₹0.00 | Close₹-- |
Circuit range₹-- - ₹-- | Day range₹0.00 - ₹0.00 | Year range₹-- - ₹-- |
Volume-- | Avg. traded₹-- | Revenue (12m)₹NaN undefined |
Ishita Drugs Industries LtdIshita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, Indole 2 Carboxylic Acid, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, methyl iodide. Its products are exported to various countries across the world.
Read more
Ishita Drugs Industries Ltd Key indicators
52 week high₹0.00 | 52 week low₹0.00 | P/E ratio |
P/B ratio | ROEN/A | ROCEN/A |
Dividend yieldN/A | Debt/Equity ratio | EPS |
Learn more
Fundamentals
Financial ratios
Operating profit marginN/A | Net profit marginN/A |
ROEN/A | ROAN/A |
ROCEN/A |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Ishita Drugs Industries Ltd Share Price history
Day | Open | Close | Day’s change |
---|
Events
No data available at the moment
More
Similar stocks
People also bought
Investment calculators
Upcoming IPOs
No data available at the moment